Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;39(12):4305-4310.
doi: 10.1007/s00345-021-03792-5. Epub 2021 Jul 27.

Robotic-assisted radical prostatectomy with the Senhance® robotic platform: single center experience

Raimundas Venckus  1 , Marius Jasenas  1 , Titas Telksnys  1 , Martynas Venckus  2 , Vinsas Janusonis  3 , Audrius Dulskas  4   5 , Narimantas E Samalavicius  1   2   6
Affiliations

Robotic-assisted radical prostatectomy with the Senhance® robotic platform: single center experience

Raimundas Venckus et al. World J Urol. 2021 Dec.

Abstract

Objective: To describe our institution's initial experience with robot-assisted radical prostatectomy (RARP) using the Senhance® robotic system.

Patients and methods: A prospective analysis of 127 robot-assisted radical prostatectomies was performed. Patient demographics, preoperative and intraoperative parameters, histopathological examination results, intraoperative and early postoperative complications were obtained and analyzed.

Results: The median patient age was 61.0 ± 6.36 (from 37 to 73) years, with a mean body mass index of 26.2 ± 3.79 kg/m2. Of 127 patients, 16.5% (n = 21) underwent a pelvic lymph node dissection, 29.1% (n = 37) underwent one sided or bilateral nerve sparing. Post-operative extracapsular invasion (≥ pT3) was found in 15% (n = 19) of the cases and a Gleason score ≥ 7 in 74.8% of all patients. Our median operative time was 180 ± 41.98 min [interquartile range (IQR) 150-215], and median blood loss was 250 ± 236 (IQR 175-430) ml. Of 127 patients, 33.9% (n = 43) had positive margins, of them 28.7% in pT2 and 57.9% in pT3. Fifteen patients (11.8%) experienced complications, of them only three had Clavien-Dindo ≥ 3. Operation time decreased by about 60 min and estimated blood loss decreased by about 200 ml from the initial experience of each surgeon.

Conclusions: Robotic prostatectomy using a Senhance® robotic system is feasible, and warrants further study to determine whether it can improve patient outcomes.

Keywords: Minimally invasive surgery; Prostate cancer; Prostatectomy; Robotic surgery; Senhance® robotic system.

PubMed Disclaimer

References

    1. Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359-386 - DOI
    1. Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67(1):7–30 - DOI
    1. Ilic D, Evans SM, Allan CA et al (2017) Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer. Cochrane Database Syst Rev 9(9):CD009625 - PubMed
    1. Oberlin DT, Flum AS, Lai JD et al (2016) The effect of minimally invasive prostatectomy on practice patterns of American urologists. Urol Oncol 34(6):255.e1–5 - DOI
    1. Gandaglia G, Montorsi F, Karakiewicz PI et al (2015) Robot-assisted radical prostatectomy in prostate cancer. Future Oncol 11(20):2767–2773 - DOI

LinkOut - more resources